* Note: Prices are in Million (M) USD.
Description:
Avanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $108 M
Debt : $125 M
EBITDA : $94 M
Net Debt (Debt - Cash): $18 M
Since Net Debt is covered by EBITDA within 1 year, 3 points assigned.
This criteria used industry in which company operates:
Sector: LIFE SCIENCES
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Message: Cannot calculate PE Ratio since EPS is either 0 or negative.
Using default values for calculation.
Forward PE Ratio (using default values): 20.00
Since Forward PE Ratio is between 20 - 25, 2 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $15 M
Average Revenue: $1,104 M
Revenue Converted To Free Cash FLow(%): 1%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 174.02%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $688 M
Revenue 4 Years Ago (2020-12-31): $715 M
Last 5 Years Average Revenue Growth: -1%
Since Revenue Growth is between 0 - 5, 1 point assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $46 M
Share Count 5 Years Ago (2020-12-31): $48 M
Company is buying back its own shares, 3 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Message: Cannot calculate payout ratio because EPS is either 0 or negative.
Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -5%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $11
52-Week Low: $11
Threshold Price (15% Above 52-Week Low): $13
Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $534 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 1% exposure of Total Portfolio.
Value-Trade has assigned 20 points to above Avanos Medical Inc (AVNS) stock.
Last 11 Years Avg PE (Limited to last 11 years of EPS data) 25, Fair Value PE 15 and Industry Based PE is 18. Based on these three values average assigned is 19.33.
The fair value of Avanos Medical Inc (AVNS) stock cannot be calculated since EBITDA and EPS are either 0 or negative.
